BioCentury
ARTICLE | Emerging Company Profile

Angiogene: Antiproliferative radiation

November 9, 1998 8:00 AM UTC

Radiation treatment has long been synonymous with cell killing. But Angiogene Inc. is taking a different approach. The company specializes in delivering radioisotopes within the nuclei of proliferating cells, not to kill them, but to stop them from dividing.

Founder Guy Leclerc started using intravascular radiation as an adjunct to stents in preventing restenosis following angioplasty, and the company plans to extend its technology to applications in late vein graft failure, restenosis in vessels such as the bile duct and urethra and tumor growth...